PMID- 37263238 OWN - NLM STAT- MEDLINE DCOM- 20230809 LR - 20230921 IS - 1662-2782 (Electronic) IS - 0302-5144 (Linking) VI - 200 DP - 2023 TI - Anticoagulation Prophylaxis in Extracorporeal Adsorption Techniques. PG - 82-87 LID - 10.1159/000527572 [doi] AB - In this chapter, anticoagulation treatments for adsorption techniques in continuous renal replacement therapy (CKRT) will be reviewed. Anticoagulation used with adsorption techniques is quite different than anticoagulation in classical CKRT with nonadsorptive therapies. Regional citrate anticoagulation (RCA) and unfractionated heparin (UFH) are the most common anticoagulation modalities for both nonselective adsorptive membranes - such as surface-treated acrylonitrile 69 membranes (AN69ST) and polymethylmethacrylate membranes - and selective adsorptive membranes such as AN69-oXiris. For these techniques, the efficacy of RCA seems to be superior to UFH. Regardless of the lack of large comparative studies in comparison to ones conducted for adsorptive filter techniques in CKRT, RCA and UFH will also be discussed for nonselective adsorptive sorbents like CytoSorb and Jafron HA. For selective adsorptive sorbents, such as polymyxin-B hemoperfusion, UFH and RCA seems to be the appropriate techniques; however, randomized controlled trials confirming this are yet to be conducted. Lastly, anticoagulation prophylaxis for more specific techniques like coupled plasma filtration adsorption and double plasma molecular adsorption system will be discussed. CI - (c) 2023 S. Karger AG, Basel. FAU - Honore, Patrick M AU - Honore PM AD - CHU UCL Godinne Namur, UCL Louvain Medical Shool, Campus Godinne, Namur, Belgium. FAU - Blackman, Sydney AU - Blackman S AD - ULB University, Brussels, Belgium. FAU - Bousbiat, Ibrahim AU - Bousbiat I AD - ULB University, Brussels, Belgium. FAU - Perriens, Emily AU - Perriens E AD - ULB University, Brussels, Belgium. FAU - Attou, Rachid AU - Attou R AD - Faculty of Medicine, ICU Department, Centre Hospitalier Universitaire Brugmann, ULB University, Brussels, Belgium. LA - eng PT - Journal Article PT - Review DEP - 20230601 PL - Switzerland TA - Contrib Nephrol JT - Contributions to nephrology JID - 7513582 RN - 9005-49-6 (Heparin) RN - 2968PHW8QP (Citric Acid) RN - 0 (Citrates) RN - 0 (Anticoagulants) SB - IM MH - Humans MH - *Heparin/pharmacology/therapeutic use MH - Adsorption MH - *Blood Coagulation MH - Citric Acid MH - Citrates MH - Anticoagulants/therapeutic use EDAT- 2023/06/02 01:07 MHDA- 2023/08/09 06:43 CRDT- 2023/06/01 18:24 PHST- 2022/07/03 00:00 [received] PHST- 2022/09/23 00:00 [accepted] PHST- 2023/08/09 06:43 [medline] PHST- 2023/06/02 01:07 [pubmed] PHST- 2023/06/01 18:24 [entrez] AID - 000527572 [pii] AID - 10.1159/000527572 [doi] PST - ppublish SO - Contrib Nephrol. 2023;200:82-87. doi: 10.1159/000527572. Epub 2023 Jun 1.